Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of intravenous administration
Moxifloxacin (BAY 12-8039) compared to intravenous ceftriaxone and metronidazole for the
treatment of patients with complicated intra abdominal infections. In view of the fact that
intra abdominal infections are typically polymicrobial and are often treated empirically, the
selected antibacterial agent must cover the likely spectrum of bacterial pathogens.
Combination antibiotics therapy has been widely used with great success.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Ceftriaxone Fluoroquinolones Metronidazole Moxifloxacin Norgestimate, ethinyl estradiol drug combination